USX:RAPT - RAPT Therapeutics Inc

RAPT Therapeutics Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts
• Options

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.54% -25.8%	2.73% 7.6%	2.65% -3.3%	2.64% -0.3%	2.48% -6.1%	2.48% -0.1%	2.07% -16.5%	1.85% -10.7%	1.91% 3.3%	1.91% 0%	1.89% -1.0%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1.22K% -	-1.47K% -	-1.81K% -	-2.26K% -	-2.35K% -	-3.45K% -	-5.49K% -	-10.46K% -	-	-	-
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1.23K% -	-1.47K% -	-1.82K% -	-2.27K% -	-2.35K% -	-3.48K% -	-5.62K% -	-10.9K% -	-	-	-
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.92M -7.7%	4.36M -11.4%	3.81M -12.5%	3.23M -15.2%	3.25M 0.5%	2.28M -29.7%	1.53M -33.1%	886K -42.0%	0 -100%	0 -	0 -
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	231.08M 118.2%	217.46M -5.9%	198.64M -8.7%	187.55M -5.6%	222M 18.4%	209.49M -5.6%	266.21M 27.1%	248.33M -6.7%	220.76M -11.1%	199.72M -9.5%	173.33M -13.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	13.5M -5.5%	15.59M 15.5%	12.26M -21.4%	19.71M 60.8%	19.86M 0.8%	20.18M 1.6%	21.04M 4.3%	27.86M 32.4%	21.08M -24.3%	26.92M 27.7%	26.29M -2.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	217.58M 137.4%	201.87M -7.2%	186.38M -7.7%	167.84M -10.0%	202.13M 20.4%	189.31M -6.3%	245.17M 29.5%	220.47M -10.1%	199.68M -9.4%	172.8M -13.5%	147.03M -14.9%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-53.15M -	-55.71M -	-61.03M -	-62.69M -	-63.97M -	-68.6M -	-70.77M -	-73.8M -	-87.41M -	-92.14M -	-97.05M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	28.96M -68.4%	20.23M -30.1%	24.92M 23.2%	24.72M -0.8%	86.22M 248.8%	60M -30.4%	24.03M -60.0%	32.42M 34.9%	57.2M 76.5%	27.71M -51.6%	38.95M 40.6%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	86.22M 248.8%	60M -30.4%	24.03M -60.0%	32.42M 34.9%	57.2M 76.5%	27.71M -51.6%	38.95M 40.6%	45.77M 17.5%	50.16M 9.6%	54.13M 7.9%	47.48M -12.3%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-53.74M -	-56.25M -	-61.78M -	-63.37M -	-65.15M -	-69.79M -	-71.62M -	-75.25M -	-88.53M -	-93.25M -	-98.17M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-59.99M -	-64.01M -	-69.2M -	-73.16M -	-76.23M -	-78.82M -	-83.84M -	-92.64M -	-98.74M -	-108.87M -	-116.8M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-59.99M -	-64.01M -	-69.2M -	-73.16M -	-76.23M -	-78.82M -	-83.84M -	-92.64M -	-98.74M -	-108.87M -	-116.8M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-2.4 -	-2.44 -	-2.53 -	-2.56 -	-2.55 -	-2.54 -	-2.58 -	-2.65 -	-2.69 -	-2.89 -	-3.05 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-35.27% -	-41.04% -	-47.64% -	-56.39% -	-36.33% -	-40.3% -	-38.85% -	-47.72% -	-49.15% -	-60.13% -	-59.56% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-32.36% -	-36.95% -	-43.58% -	-49.86% -	-33.65% -	-36.92% -	-36.07% -	-42.51% -	-44.6% -	-53.21% -	-53.15% -